<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04726878</url>
  </required_header>
  <id_info>
    <org_study_id>KE-0254/92/2018</org_study_id>
    <nct_id>NCT04726878</nct_id>
  </id_info>
  <brief_title>ESP in Breast Surgery Due to Cancer</brief_title>
  <official_title>Effectiveness of the Erector Spinae Plane Block in Patients Undergoing Breast Surgery Due to Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients scheduled for breast surgery due to cancer. Each patient will be treated with&#xD;
      intravenous (i.v.) oxycodone - patient-controlled analgesia (PCA). Patients will be allocated&#xD;
      to one of three groups: erector spinae plane (ESP) block, sham block, controlled group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Only patients who are qualified for an elective procedure of mitral breast surgery may&#xD;
      participate in the study. Each patient will be anesthetized generally. The same drugs will be&#xD;
      used in each stage of anesthesia. The induction: propofol, fentanyl, rocuronium. The airway&#xD;
      will be secured with a laryngeal mask airway (LMA). When there is a risk of aspiration, the&#xD;
      patient will be intubated. Then, rocuronium or suxamethonium will be used. The anesthesia&#xD;
      maintenance: sevoflurane, fentanyl. The emergence: oxygen, sugammadex or neostigmine a&#xD;
      required.&#xD;
&#xD;
      After the induction of general anesthesia, an opaque envelope with the selected group will be&#xD;
      opened. In the controlled group, the procedure will be continued in the patient's supine&#xD;
      position. Women from the ESP and Sham groups will be placed in the lateral position. The&#xD;
      operated side will be above. Then, the ultrasound-guided ESP block with saline or ropivacaine&#xD;
      will be performed.&#xD;
&#xD;
      At the end of the surgery, an anesthesiologist will administer oxycodone intravenously (0.1&#xD;
      mg/KG).&#xD;
&#xD;
      After emergence from anesthesia, the patient will be transferred to the postoperative care&#xD;
      unit. Vital signs will be monitored. The patient-controlled analgesia pump with oxycodone&#xD;
      will be used.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">August 17, 2021</completion_date>
  <primary_completion_date type="Actual">August 12, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized 1:1:1</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The patient: The primary intervention (erector spinae plane block) will be provided under general anesthesia.&#xD;
The investigator and outcome assessor will be not aware of the allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of recovery 40</measure>
    <time_frame>Before the hospital discharge</time_frame>
    <description>Quality of recovery (QoR) score containing 40 items. This questionnaire measures the early postoperative health status of patients. Minimum is 40, maximum is 200. More points is better.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient-controlled analgesia (PCA)</measure>
    <time_frame>24 hours from the connection of the PCA pump in the post-anesthesia care unit.</time_frame>
    <description>All good and bad demands with PCA pump.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale</measure>
    <time_frame>up to 24 hours after the surgery</time_frame>
    <description>Acute pain measured with VAS (visual analog scale). From 0 (no pain) to 100. More on the scale is worse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total oxycodone consumption</measure>
    <time_frame>up to 24 hours after the surgery</time_frame>
    <description>Consumption of oxycodone with PCA pump, loading, and additional doses.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Pain, Acute</condition>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard care without regional block. General anesthesia. After the end of the surgery, the patient-controlled analgesia with oxycodone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESP block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.375% ropivacaine will be performed. Then, the patient will be treated as in the controlled group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham block</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>After the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.9% saline will be performed. Then, the patient will be treated as in the controlled group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector spinae plane block</intervention_name>
    <description>Ultrasound-guided the erector spinae plane block with 0.375% ropivacaine, 0.4 mL per KG, up to 40 mL (maximum dose).</description>
    <arm_group_label>ESP block</arm_group_label>
    <other_name>ESP block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham block</intervention_name>
    <description>Ultrasound-guided the erector spinae plane block with 0.9% saline, 0.4 mL per KG, up to 40 mL (maximum dose).</description>
    <arm_group_label>Sham block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <description>Standard general anesthesia. The induction with fentanyl, 1-3 mcg per KG; propofol, 1.5-2 mg per kg. Then, the laryngeal mask airway will be inserted. Patients with the risk of aspiration will be intubated using rocuronium or suxamethonium.&#xD;
The maintenance with oxygen/air mixture, sevoflurane, and fentanyl.</description>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_label>ESP block</arm_group_label>
    <arm_group_label>Sham block</arm_group_label>
    <other_name>GA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Patient-controlled analgesia</intervention_name>
    <description>All patients will receive a PCA pump with oxycodone (1 mg/mL, 5-minute interval) after transfer to PACU (post-anesthesia care unit)</description>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_label>ESP block</arm_group_label>
    <arm_group_label>Sham block</arm_group_label>
    <other_name>PCA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <description>Intravenous oxycodone will be administered about 30 minutes before the end of the surgery at a dose of 0.1 mg/KG. Additional 2 doses can be given if pain on the visual analog scale will be higher than 40.</description>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_label>ESP block</arm_group_label>
    <arm_group_label>Sham block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>intravenous paracetamol will be used (1.0 gram), up to 4 grams per day</description>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_label>ESP block</arm_group_label>
    <arm_group_label>Sham block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective surgery of breast due to cancer&#xD;
&#xD;
          -  obtained consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  the lack of consent&#xD;
&#xD;
          -  the surgery of two breasts&#xD;
&#xD;
          -  reoperation of the same breast&#xD;
&#xD;
          -  previous participation in the study&#xD;
&#xD;
          -  coagulopathy&#xD;
&#xD;
          -  allergy to morphine and local anesthetics&#xD;
&#xD;
          -  depression, antidepressant drugs treatment&#xD;
&#xD;
          -  epilepsy&#xD;
&#xD;
          -  usage of painkiller before surgery&#xD;
&#xD;
          -  addiction to alcohol or recreational drugs&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paweł Piwowarczyk, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Lublin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>II Department of Anesthesia and Intensive Care, Medical University of Lublin</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 23, 2021</study_first_submitted>
  <study_first_submitted_qc>January 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Michał Borys</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>erector spinae plane block</keyword>
  <keyword>visual analog scale</keyword>
  <keyword>quality of recovery</keyword>
  <keyword>patient-controlled analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

